Mankind Pharma QIP: The indicative issue price for the QIP is expected to be approximately ₹2,520 per share, which could lead to an equity dilution of 2.9% on a post-issue basis, sources added.
Mankind Pharma QIP: The indicative issue price for the QIP is expected to be approximately ₹2,520 per share, which could lead to an equity dilution of 2.9% on a post-issue basis, sources added.